¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѼö¸éÀÇÇÐȸ 2019 Ãß°èÇмú´ëȸ : 2019-10-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѼö¸éÀÇÇÐȸ 2019 Ãß°èÇмú´ëȸ : 2019-10-25
±³À°ÀÏÀÚ : 2019-10-25
±³À°Àå¼Ò : ¼­¿ï´ëÇб³ ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç ¹× ½Ãû°¢½Ç  
±³À°ÁÖÁ¦ : ´ëÇѼö¸éÀÇÇÐȸ 2019 Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѼö¸éÀÇÇÐȸ
´ã´çÀÚ : ¼­¹ÎÁ¤
¿¬¶ôó : 02-445-1611  
À̸ÞÀÏ : kasmedorkr@gmail.com      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤½Å°Ç°­ÀÇÇаú, À̺ñÀÎÈÄ°ú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í ´ëȸºñ (ÇöÀåµî·Ï) - Á¤È¸¿ø: 4¸¸¿ø / ºñȸ¿ø: 6¸¸¿ø / Àü°øÀÇ: 2¸¸ 5õ¿ø /±âŸ: 2¸¸ 5õ¿ø / Æò»ýȸ¿ø: 1¸¸¿ø ´ëȸºñ (»çÀüµî·Ï) - Á¤È¸¿ø: 3¸¸¿ø / ºñȸ¿ø: 4¸¸¿ø / Àü°øÀÇ: 2¸¸¿ø / ±âŸ: 2¸¸¿ø / Æò»ýȸ¿ø: ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-25 ´ë°­´ç 09:30~10:00 Treatment guideline of chronic insomnia  À̼ÒÁø(°æ»óÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 10:00~10:25 Treatment guideline of RLS  ÀÓÈñÁø(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 10:25~10:50 Hypersomnia : etiology and management  ÀüÈ«ÁØ(°Ç±¹´ëº´¿ø) 
È޽Ġ10-25  10:50~11:10   () 
±³À°½Ã°£ 10-25 ´ë°­´ç 11:10~11:40 Circadian rhythm regulation  À±È£°æ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 11:40~12:05 Sleep and performance/learning  Àü¼¼Çö(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-25 ´ë°­´ç 12:05~12:30 Sleep and neurodegeneration  ±èÁ¤ºó(°í·ÁÀÇ´ë) 
½Ä»ç 10-25  12:30~13:30   () 
±³À°½Ã°£ 10-25 ´ë°­´ç 13:30~14:30 Sleep-promoting substances and the ventrolateral preoptic area  À̸¸±â(°æºÏÀÇ´ë) 
È޽Ġ10-25  14:30~14:40   () 
±³À°½Ã°£ 10-25 ´ë°­´ç 14:40~15:00 PAP Therapy for OSA: Recent Updates  ±è¼¼¿ø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 15:00~15:20 Personalized Sleep Apnea Therapy and Adherence  °­ÇöÈñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 15:20~15:45 Facial characteristics of children with OSA  ±è¸í¸³(Àϸ®³ëÀÌÄ¡°ú) 
±³À°½Ã°£ 10-25 ´ë°­´ç 15:45~16:10 Upper airway stimulation therapy for obstructive sleep apnea  È«¼®Áø(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 16:10~16:30 Epidemiological big data analysis in sleep medicine  Á¤¼±Àç(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 16:30~16:50 The Influence of Physical Environmental Factors on Sleep  Á¤¼±Àç(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 16:50~17:15 Application of deep learning for apnea and sleep stage classification  ¹Î°æº¹(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-25 ´ë°­´ç 17:15~17:40 -  ¼Õ±âÈÆ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 09:30~10:00 Indications for polysomnography  ½ÅÈ«¹ü(ÄÚ½½¸³¼ö¸éÀÇ¿ø) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 10:00~10:30 Practice parameters for the use of MSLT and recommendation for protocols  À̹ÌÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 10:30~11:00 Parameters to be reported for polysomnography  ¼Ò¹Î¾Æ(±¹¸³Á¤½Å°Ç°­¼¾ÅÍ) 
È޽Ġ10-25  11:00~11:10   () 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 11:10~11:50 Scoring sleep staging and arousals  ¿À¼º¹Î(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 11:50~12:30 Scoring respiratory and movement events  ÃÖÀç¿ø(À»ÁöÀÇ´ë) 
½Ä»ç 10-25  12:30~03:30   () 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 14:40~15:00 How can we measure chronotype and seasonality?  ¼Ò¹Î¾Æ(±¹¸³Á¤½Å°Ç°­¼¾ÅÍ) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 15:00~15:20 Chronotype and seasonality: Is this natural or the result of adaptation?  Á¶Ã¶Çö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 15:20~15:45 Relationship between chronotype/seasonality and suicidality  ±èÀº¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 15:45~16:10 Relationship between chronotype/seasonality and metabolism  ±è°æÁø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 16:10~16:40 Diagnostic challenges by multiple sleep latency test for hypersomnolence.  ¿À¼º¹Î(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 16:40~17:10 Neurobiology of narcolepsy and Idiopathic hypersomnia  °­½Â°É(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10-25 ½Ãû°¢±³À°½Ç 17:10~17:40 Scoring respiratory and movement events  ÃÖÀç¿ø(À»ÁöÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѼö¸éÀÇÇÐȸ 2019 Ãß°èÇмú´ëȸ : 2019-10-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019 ´ë±¸ ․ °æºÏ Á¤Çü¿Ü°úÁöȸ ¿ù·Êȸ ¹× ÀÇ»çȸ Ãß°è ¿¬¼ö°­Á : 2019-10-25
´ÙÀ½±Û ´ëÇÑ»ý¹°Á¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2019-10-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20835 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ 2024³â Á¦ 1ȸ ³»½Ã°æ Áý´ãȸ : 2024-06-21 0 4 2024-05-27
20834 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-21 0 1 2024-05-27
20833 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 1ÀÏÂ÷ : 2024-06-21 0 2 2024-05-27
20832 ¼­¿ï Á¦8Â÷ µµºÀ±¸ÀÇ»çȸ Çмú¼¼¹Ì³ª(½ÉÇ÷°üÁúȯ ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á, ºÒ¸éÁõ, Ä¡¸Å¾à¹°Ä¡·á, Ç×Ç÷ÀüÁ¦) : 2024-06-21 0 0 2024-05-27
20831 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2024-06-21 0 1 2024-05-27
20830 Á¦ÁÖ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-21 0 0 2024-05-27
20829 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(1ÀÏÂ÷) : 2024-06-20 0 0 2024-05-27
20828 ºÎ»ê ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2024-06-20 0 5 2024-05-27
20827 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 510ȸ ÇмúÁý´ãȸ : 2024-06-20 0 1 2024-05-27
20826 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (1ÀÏÂ÷) : 2024-06-20 0 0 2024-05-27
20825 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÅëÁõÇÐȸ ¼­¿ïÁöȸ Áý´ãȸ : 2024-06-20 0 0 2024-05-27
20824 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¼­½Ä ÀÛ¼º ½ÇÁ¦) : 2024-06-20 0 0 2024-05-27
20823 °æ±â µ¿±¹´ëÇб³ Àϻ꺴¿ø : °ñ°üÀý¿°ÀÇ Áø´Ü ¹× Ä¡·á : 2024-06-19 0 2 2024-05-27
20822 °æ±â ´ëÇÑ°£ÇÐȸ Overlooked Liver Diseases : 2024-06-19 0 7 2024-05-27
20821 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦2ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-06-17 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷